Showing results (1-10 of 162) with videos related to
Sort By:
Pageof 17
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2025
Nuclear Alpha-Synuclein: Mechanisms and Implications for SynucleinopathiesTiago Fleming Outeiro, David J KossJournal of Neurochemistry|March 14, 2024
Altered hippocampal doublecortin expression in Parkinson's diseaseEvelini Plácido, David J Koss, Tiago Fleming Outeiro, et al.Journal of Neurochemistry|April 21, 2019
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategiesAmir Tayaranian Marvian, David J Koss, Farhang Aliakbari, et al.Molecular Neurobiology|January 7, 2021
Alpha-Synuclein Antibody Characterization: Why Semantics MattersTiago Fleming OuteiroFEMS Yeast Research|June 29, 2010
Simple is good: yeast models of neurodegenerationSandra Tenreiro, Tiago Fleming OuteiroMolecular Neurobiology|February 8, 2013
Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopySusana Gonçalves, Tiago Fleming OuteiroCurrent Pharmaceutical Design|September 16, 2009
Current and future therapeutic strategies for Parkinson's diseaseTiago Fleming Outeiro, Joaquim FerreiraPerspectives in Medicinal Chemistry|September 30, 2009
Drug Targeting of alpha-Synuclein Oligomerization in SynucleinopathiesTiago Fleming Outeiro, Aleksey KazantsevBrain : a Journal of Neurology|August 1, 2023
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathiesAvika Chopra, Tiago Fleming OuteiroPageof 17